| Ferric Citrate |
Tablet |
II (Paddle) |
100 |
EDTA media ( 2.0 grams of EDTA Na2 2H2O to 1000 mL of purified water) |
900 |
10, 20, 30, 45 and 60 |
2015/08/27 |
| Ferric Maltol |
Capsule |
II (Paddle with sinker) |
75 |
Tier 1: KCl/HCl Buffer, pH 1.2; Tier 2: KCl/HCl Buffer pH 1.2, with pepsin |
1000 |
5, 10, 20, 30 and 45 |
2020/01/30 |
| Ferrous Fumarate |
Tablet |
|
|
Refer to USP |
|
|
2016/03/17 |
| Fesoterodine Fumarate |
Tablet (Extended Release) |
II (Paddle) with sinker |
75 |
Phosphate Buffer, pH 6.8 |
900 |
1, 2, 4, 6, 8, 10, 12, 16 and 20 hours |
2013/08/15 |
| Fexinidazole |
Tablet |
II (Paddle) |
75 |
0.1 N HCl with 3% w/v SLS |
2000 |
10, 20, 30, 40, 50 and 60 |
2023/05/18 |
| Fexofenadine HCl |
Tablet (Orally Disintegrating) |
II (Paddle) |
50 |
0.001 N HCl |
500 |
5, 10, 15, 30 and 45 |
2008/09/03 |
| Fexofenadine HCl |
Suspension |
II (Paddle) |
50 |
0.001 N HCl |
900 |
10, 20, 30 and 45 |
2008/11/25 |
| Fexofenadine HCl |
Tablet |
II (Paddle) |
50 |
0.001 N HCl |
900 |
5, 10, 20, 30 and 45 |
2004/02/19 |
| Fexofenadine HCl |
Capsule |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
| Fexofenadine HCl/Pseudoephedrine HCl |
Tablet (Extended Release) |
|
|
Refer to USP |
|
|
2009/04/02 |
| Fezolinetant |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2024/08/05 |
| Fidaxomicin |
For Oral Suspension |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
| Fidaxomicin |
Tablet |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
| Finafloxacin |
Otic Suspension |
|
|
Develop a method to characterize in vitro release |
|
|
2016/03/17 |
| Finasteride |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Finasteride; Tadalafil |
Capsule |
|
|
Develop a dissolution method |
|
|
2024/02/05 |
| Finerenone |
Tablet |
II (Paddle) |
75 |
Acetate Buffer, pH 4.5 (for 10 mg strength) and Acetate Buffer, pH 4.5 with 0.1% polysorbate 20 (for 20 mg strength) |
900 |
5, 10, 15, 20 and 30 |
2023/02/09 |
| Fingolimod |
Capsule |
I (Basket) |
100 |
0.1 N HCl with 0.2% SDS (sodium dodecyl sulfate) |
500 |
5, 10, 15, 20 and 30 |
2013/08/15 |
| Fingolimod Lauryl Sulfate |
Tablet, Orally Disintegrating |
II (Paddle) with sinker |
50 |
0.1 N HCl with 0.2% sodium dodecyl sulfate (SDS) |
500 |
5, 10, 15, 20, 25, 30 and 45 |
2023/11/30 |
| Flavoxate HCl |
Tablet |
I (Basket) |
100 |
0.1 N HCl |
900 |
5, 10, 20 and 30 |
2004/01/29 |